Atrial Natriuretic Peptide Protects Against Ischemia-Reperfusion Injury in the Isolated Rat Heart
|
|
- Tabitha Fowler
- 6 years ago
- Views:
Transcription
1 Atrial Natriuretic Peptide Protects Against Ischemia-Reperfusion Injury in the Isolated Rat Heart Kenji Sangawa, MD, Koji Nakanishi, MD, Kozo Ishino, MD, Masahiro Inoue, MD, Masaaki Kawada, MD, and Shunji Sano, MD Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan Background. Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis. The purpose of this study was to investigate the cardioprotective effects of ANP against ischemia-reperfusion injury in isolated rat hearts. Methods. Twenty-four hearts were perfused with ANP at 0.01, 0.1, and 1 mol/l or without ANP (n 6 each) in normoxic conditions. Because 0.1 mol/l ANP induced a threefold increase in cyclic guanosine monophosphate release into the coronary effluent without any effect on cardiac function, we used the 0.1 mol/l ANP dose for ischemia-reperfusion studies. Eighteen hearts were subjected to 15 minutes of normothermic global ischemia followed by 15 minutes of reperfusion. The hearts were divided into three groups (n 6 each). In group 1, ANP was added before ischemia. In group 2, ANP was added to the reperfusate. Hearts were untreated in the control group. Results. In group 1, the postischemic recovery of cardiac output, coronary flow, and cyclic guanosine monophosphate release was similar to the control group. In group 2, the recovery of cardiac output was significantly better than the control group (82.1% 9.8% vs 61.8% 6.8%, respectively, p < 0.01) with a similar trend to recovery of coronary flow (90.7% 8.5% vs 79.3% 11.8%, respectively). The improved cardiac function was closely related to a significant increase in postischemic cyclic guanosine monophosphate release. Conclusions. Administration of ANP at the time of reperfusion protects the myocardium from ischemiareperfusion injury. The concentrations of administration must not only increase the release of cyclic guanosine monophosphate release, but also lack negative inotropic effects. (Ann Thorac Surg 2004;77:233 7) 2004 by The Society of Thoracic Surgeons Accepted for publication July 30, Address reprint requests to Dr Ishino, Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine and Dentistry, Shikata-cho, Okayama-City , Japan; ishino@tb3.so-net.ne.jp. Ischemia-reperfusion injury after regional or global ischemia involves damage to cardiomyocytes, vascular smooth muscle, and endothelial cells. When cardiomyocytes are reoxygenated after a prolonged period of energy depletion, severe cytosolic calcium overload and reactivation of energy production cause deleterious hypercontracture, which leads to cell disruption in tissue ( oxygen paradox [1]). Recent experimental studies have demonstrated that reoxygenation-induced hypercontracture can be prevented if the contractile apparatus is temporarily blocked during the initial phase of reoxygenation to reestablish normal cytosolic calcium control [2]. Myocardial guanosine 3, 5 -cyclic monophosphate (cgmp), which reduces calcium sensitivity of myofilaments [3], is severely depleted during reperfusion after prolonged ischemia [4, 5]. Increasing cgmp synthesis by atrial natriuretic peptide (ANP), a stimulator of the particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes [6]. However, it has been suggested that too high concentration of cgmp could be detrimental to reperfused myocardium because of its contractile inhibitory action [5], subsequently leading to apoptotic cell death [7]. In the present study, we initially determined the optimal concentration of ANP to induce a sufficient increase in cgmp synthesis without producing negative inotropic effects in normoxic perfused hearts. We then investigated the cardioprotective effects of ANP against ischemiareperfusion injury in isolated rat hearts. Material and Methods Isolated Perfused Rat Heart We modified and used an isolated, perfused, rat heart apparatus that was previously described by Hearse and associates [8]. This circuit was designed to work in two interconvertible perfusion conditions, which were the Langendorff and working modes. In the former mode, 2004 by The Society of Thoracic Surgeons /04/$30.00 Published by Elsevier Inc doi: /s (03)
2 234 SANGAWA ET AL Ann Thorac Surg MYOCARDIAL PROTECTION BY ANP 2004;77:233 7 The pulmonary artery was incised to facilitate coronary drainage. The heart was then perfused in a retrograde manner under Langendorff mode perfusion conditions at 37.0 C for 10 minutes. Fig 1. Experimental protocol for normoxic study. Atrial natriuretic peptide (0.01, 0.1, 1 mol/l) was added to the perfusate for 15 minutes of working perfusion (W2). (cgmp cyclic guanosine monophosphate; L Langendorff perfusion; W working perfusion.) hearts were perfused through the aorta at a pressure of 80 cm H 2 O and continued to beat without external work. In the latter mode, hearts were perfused through the left atrium at an atrial pressure of 20 cm H 2 O. The left ventricle spontaneously ejected against a hydrostatic pressure of 100 cm H 2 O. The hearts were not paced. Only aortic flow was pooled and recirculated, but coronary effluent was discarded. The perfusate was a modified Krebs-Henseleit bicarbonate buffer (KHB) that was composed of the following (in mmol/l): NaCl, 118; NaHCO 3, 25; KCl, 4.7; CaCl 2, 2.5; MgSO 4, 1.2; KH 2 PO 4, 1.2; and glucose, 11. The KHB was bubbled with 95% oxygen and 5% carbon dioxide gas at 37.0 C to maintain the aortic partial pressure of oxygen higher than 500 mm Hg. It was then filtered through a cellulose acetate membrane (pore size 0.45 m) to remove any particulate contaminants [9]. Male Wister rats weighing 280 to 380 g were used in all experiments. Forty-two hearts were allocated to either normoxic or ischemic-reperfusion studies. Six hearts were investigated in each group. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (National Institutes of Health publication 85-23, revised 1985). The animals were anesthetized with diethyl ether. The femoral vein was exposed, and heparin (200 IU) was injected. The abdominal cavity was opened through a transverse incision, the diaphragm was transected, and lateral incisions were made along both sides of the rib cage. The anterior chest wall was folded back. The heart was excised and immediately placed into cold (4 C) KHB. The aorta and left atrium were cannulated within 1 minute after excision. Normoxic Study We determined the dose of ANP ( -human atrial natriuretic peptide; Suntory Co, Tokyo, Japan) that would induce the maximum increase in myocardial cgmp concentration without negative inotropic effects. Twentyfour hearts were perfused under normoxic conditions. The experimental protocol is depicted in Figure 1. After 10 minutes of Langendorff perfusion, conditions were switched to the working mode. Heart rate, coronary flow, and cardiac output were measured every 5 minutes, and the values were averaged to assess cardiac function. Heart rate was obtained from the aortic pressure tracing. Aortic flow was measured in the aortic column by an electromagnetic flowmeter (MFV-1100; Nihon Koden Co, Tokyo, Japan). The coronary flow was measured by timed volumetric collection from the right side of the heart. Cardiac output was calculated by summing the aortic and coronary flows. The coronary effluent was collected for 1 minute to measure the release of cgmp. After the second Langendorff perfusion, hearts were again perfused in the working mode with medium containing 0.01, 0.1, and 1 mol/l ANP (n 6 in each concentration). The coronary effluent was discarded to keep ANP concentration at a constant level in the circuit. Six hearts were perfused without ANP (control). After the second working perfusion, assessment of cardiac function was repeated, and the coronary effluent was collected for the measurement of cgmp release. Hearts were removed from the apparatus at the end of each experiment and heated to 70 C for 14 days. Hearts were then reweighed to determine the dry weight of the ventricular myocardium. The concentration of cgmp was determined by radioimmunoassay as previously described [10] and was expressed in picomoles per grams dry weight per minute. Results are presented in Table 1. Cardiac function after the second working perfusion is expressed as a percentage of the value obtained during the initial working perfusion without ANP. Heart rate and coronary flow were not affected by any concentration of ANP. The Table 1. Percent Changes in Heart Rate, Coronary Flow, Cardiac Output, and Cyclic Guanosine Monophosphate Leakage With Administration of Atrial Natriuretic Peptide Variable Control Atrial Natriuretic Peptide Heart rate (%) Coronary flow (%) Cardiac output (%) a Cyclic GMP (%) a a a p 0.01 versus control. GMP guanosine monophosphate.
3 Ann Thorac Surg SANGAWA ET AL 2004;77:233 7 MYOCARDIAL PROTECTION BY ANP Fig 2. Experimental protocol for ischemia-reperfusion study. (cgmp cyclic guanosine monophosphate; L Langendorff perfusion; W working perfusion.) Table 2. Heart Rate, Coronary Flow, and Cardiac Output During Working Mode Perfusion Before Ischemia Variable Control Group 1 Group 2 Heart rate (beats/min) Coronary flow (ml/min) Cardiac output (ml/min) Cyclic GMP (pmol dry weight 1 min 1 ) cardiac output of hearts perfused with 0.01 and 0.1 mol/l ANP did not change. However, the cardiac output of hearts perfused with 1 mol/l ANP was significantly lower than control hearts. Both 0.1 and 1 mol/l ANP induced a threefold increase in cgmp release (mean cgmp release; 19.2 to 65.5 pmol/grams dry weight per minute by 0.1 mol/l, 32.8 to 84.6 pmol/grams dry weight per minute by 1 mol/l). Ischemia-Reperfusion Study Because addition of 0.1 mol/l ANP to the perfusate significantly increased cgmp leakage and did not change cardiac function in the normoxic study, we used a concentration of ANP at 0.1 mol/l in the ischemiareperfusion study. Another reservoir was filled with the KHB containing 0.1 mol/l ANP and was connected to the aortic cannula. Thus hearts could be separately perfused with the KHB only or the KHB containing ANP. The experimental protocol is shown in Figure 2. After an initial washout period, hearts were perfused in the working mode for 20 minutes. During this phase, heart rate, coronary flow, and cardiac output were measured every 5 minutes, and the averages were considered as the preischemic indices. After 10 minutes of Langendorff perfusion, hearts were subjected to global ischemia by clamping the aortic and atrial inflow lines. The hearts were then maintained at 36.5 to 37.0 C for 15 minutes in the sealed chamber. Hearts were reperfused for 15 minutes in the Langendorff mode, followed by perfusion in the working mode for the next 20 minutes. The postischemic cardiac function was evaluated at the end of this phase. Eighteen hearts were allocated to one of the following three groups (n 6 in each): group 1, hearts were perfused with ANP during 10 minutes of Langendorff perfusion immediately before ischemia; group 2, hearts were perfused with ANP during 15 minutes of Langendorff perfusion immediately after ischemia; control group, hearts were untreated. Inasmuch as coronary effluent was discarded, the circuit was not contaminated by ANP. In all groups, the release of cgmp into the coronary effluent was measured at the end of the following perfusion phases; preischemic working perfusion (W1), preischemic Langendorff perfusion (L2), postischemic Langendorff perfusion (L3), and postischemic working perfusion (W3; Fig 2). GMP guanosine monophosphate. Criteria for Exclusion At the first hemodynamic evaluation, hearts presenting with a heart rate of less than 250 beats/min or aortic flow of less than 60 ml/min were considered to have suffered from myocardial damage during the preparation. These hearts were excluded from the study. Statistical Analysis All data were expressed as mean standard deviation. Differences among groups were first determined by the one-way-analysis of variance. Intergroup analysis was completed by multiple comparisons using the Dunnett test, when significance was indicated. A p value of less than 0.05 was regarded as statistically significant. Results Heart rate, coronary flow, cardiac output, and cgmp concentration in the coronary effluent determined during the preischemic working perfusion were not different among the groups (Table 2). The postischemic recoveries of heart rate, coronary flow, and cardiac output are expressed as a percentage of the preischemic value and are listed in Table 3. Changes in cgmp release are shown in Figure 3. There was no difference in the extent of functional recovery between group 1 hearts and control hearts. The cgmp release at the end of the postischemic Langendorff perfusion in group 1 was similar to the initial preischemic value, despite a significant increase at the end of the preischemic Langendorff perfusion. In group 2, the postischemic recovery of cardiac output was significantly better than the control group with a similar trend to recovery of Table 3. Postischemic Recovery of Heart Rate, Coronary Flow, and Cardiac Output Variable Control Group 1 Group 2 Heart rate (%) Coronary flow (%) Cardiac output (%) a a p 0.01 versus control.
4 236 SANGAWA ET AL Ann Thorac Surg MYOCARDIAL PROTECTION BY ANP 2004;77:233 7 Fig 3. Changes in cyclic guanosine monophosphate (cgmp) leakage in ischemia-reperfusion study. Control group (white bars) is compared with group 1 (striped bars) and group 2 (black bars). Error bar represents standard deviation. *p 0.01 versus control. (L2, L3 Langendorff perfusion periods 2, 3; W1, W3 working perfusion periods 1, 3.) coronary flow, although neither reached preischemic values. The improved cardiac function in group 2 was closely related to a significant increase in cgmp release at the end of the postischemic Langendorff perfusion. Comment The present study has shown that the administration of ANP elicited a significant improvement in the postischemic recovery of cardiac function in hearts that underwent 15 minutes of normothermic global ischemia. Resultant increases in cgmp release after the initial 15 minutes of reperfusion indicated that the protective effects of ANP against ischemia-reperfusion injury would be mediated, at least in part, by a direct effect of cgmp on cardiomyocytes. The timing of treatment application to increase cgmp for protection against hypoxia-reoxygenation or ischemia-reperfusion injury has been controversial. In hypoxia-reoxygenation studies, the temporary presence of cgmp-raising agents, such as ANP [6] and nitric oxide donors [11], is required from the last minutes of anoxia to the initial phase of reoxygenation to prevent reoxygenation-induced hypercontracture in isolated cardiomyocytes. Agullo and colleagues [12] reported that l-arginine supplementation before hypoxia increases cgmp release during reoxygenation and improves functional recovery in isolated rat hearts submitted to 40 minutes of hypoxia. Recent ischemia-reperfusion studies [4, 5] have demonstrated that urodilatin, a member of the natriuretic peptide family, improves functional recovery when administered at the time of reperfusion. It also limits myocardial necrosis in isolated rat hearts submitted to 60 minutes of ischemia. In the present study, administration of ANP during the initial reperfusion improved postischemic recovery, but no improvement was observed when added to the perfusate before ischemia. Reperfusion-induced hypercontracture occurs only after intracellular acidosis is corrected on restoration of myocardial oxygen supply. Hence, this time window could allow treatment applications of ANP at reperfusion to exert protective effects that increase the concentration of cgmp. The relation between cgmp concentration in reperfused myocardium and the extent of protective effects against reperfusion injury is not known. It has been suggested that overstimulation of cgmp synthesis could be detrimental to reperfused myocardium and may result in enhanced apoptotic cell death [7]. Padilla and associates [5] clearly demonstrated this negative effect of too high levels of cgmp in isolated rat hearts that received large doses of urodilatin after 40 minutes of ischemia. Therefore, it is important to determine the doses of agents necessary to obtain the targeted increase of cgmp in reperfused myocardium. The actual cellular cgmp concentrations were not measured in this study. However, changes in cgmp release into the coronary effluent have been shown to be a reliable index of changes in myocardial cgmp synthesis in previous studies [4]. In the present study, 0.1 mol/l ANP, which induced an increase in cgmp release but lacked negative hemodynamic effects in normoxic hearts, showed cardioprotective action in the ischemia-reperfused hearts. However, the response of myocardial cgmp synthesis to ANP might be different between normoxic and ischemic conditions. Previous studies have demonstrated that ANP directly causes cytosolic acidification by means of cgmp signaling by disabling sarcolemmal sodium hydrogen exchange [13, 14]. Inasmuch as cytosolic acidification depresses myofilament sensitivity to calcium and causes reductions in tension development and contraction amplitude [15], negative inotropic effects of ANP are mediated in part by a desensitizing effect of cgmp on myofilaments. Although the effects of ANP on intracellular calcium kinetics remain unclear, it has been reported that ANP decreases calcium current through the activation of cgmp-dependent protein kinase [16]. Furthermore, cgmp is thought to modulate calcium efflux by stimulating the sarcolemmal sodium calcium exchanger [17]. We believe that, in the present study, either enhanced or prolonged acidosis, or both, or improved calcium kinetics could explain the beneficial effect of ANP at 0.1 mol/l on contractile recovery after 15 minutes of normothermic global ischemia. An experimental study has presented evidence for the existence of an independently functioning local reninangiotensin system in the heart [18]. In the isolated perfused rat heart, angiotensin II exacerbated ischemiainduced ventricular fibrillation and impaired cardiodynamics, whereas these deleterious effects were abolished by ANP [19]. Morales and coworkers [20] reported that a direct blockade of the local renin-angiotensin system with angiotensin II receptor antagonists ameliorates myocardial stunning after global ischemia. Hence, functional antagonism of angiotensin II may underlie the protective effect of ANP against ischemia-reperfusion injury.
5 Ann Thorac Surg SANGAWA ET AL 2004;77:233 7 MYOCARDIAL PROTECTION BY ANP There are several limitations in our study. First, exact effects of ANP on postischemic recovery of left ventricular contractility were not evaluated, as we measured cardiac output instead of the maximum rate of increase of left ventricular pressure and end-diastolic pressure as our indicator of left ventricular function. Second, we did not confirm a cause and effect relationship between cgmp and postischemic recovery by using cgmp analogs and antagonists. However, previous studies using isolated rat heart models demonstrated that improved functional recovery by administration of the natriuretic peptide urodilatin during initial reperfusion after 40 minutes of ischemia was reproduced by the cgmp analog 8-bromo-cGMP [4], and that reduction in lactate dehydrogenase release by urodilatin after 60 minutes of ischemia was abolished by adding the ANP receptor antagonist isatin [5]. Third, we used an isolated perfused preparation. Although the preparation was denervated, direct cardiac responses can be studied independent of the systemic effects of ANP. Fourth, we used a crystalloid solution in the perfusion circuit. Blood perfusion may have induced different results from those of crystalloid perfusion [21]. Because each blood component serves different roles during ischemia and reperfusion and may confuse our results, we used a simple crystalloid solution in this initial study. Our data indicate that ANP could protect the myocardium from ischemia-reperfusion injury when applied at the beginning of reperfusion. Furthermore, we used concentrations that maximally increased cgmp content without inducing negative inotropic actions in normoxic myocardium. If proper doses of ANP can be determined in patients undergoing cardiopulmonary bypass, controlled reperfusion with ANP could be a beneficial adjunctive for myocardial protection during open heart surgery. This study was supported in part by the Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Science, and Culture in Japan (No ). We thank Zeria Pharmaceutical Corporation, Tokyo, Japan, for providing ANP as a generous gift. References 1. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 1973;5: Siegmund B, Klietz T, Schwartz P, Piper HM. Temporary contractile blockade prevents hypercontracture in anoxicreoxygenated cardiomyocytes. Am J Physiol 1991;260:H Shah AM, Spurgeon HA, Sollot SJ, Talo A, Lakatta EG. 8-Bromo-cGMP reduces the myofilaments response to Ca 2 in intact cardiac myocytes. Circ Res 1994;74: Inserte J, Garcia-Dorado D, Agullo L, Paniagua A, Soler- Soler J. Urodilatin limits acute reperfusion injury in the isolated rat heart. Cardiovasc Res 2000;45: Padilla F, Garcia-Dorado D, Agullo L, et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 2001;51: Hempel A, Friedrich M, Schluter KD, Forssmann WG, Kuhn M, Piper HM. ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. Am J Physiol 1997;273:H Taimor G, Hofstaetter B, Piper HM. Apoptosis induction by nitric oxide in adult cardiomyocytes via cgmp-signaling and its impairment after simulated ischemia. Cardiovasc Res 2000;45: Hearse DJ, Stewart DA, Braimbridge MV. Hypothermic arrest and potassium arrest. Circ Res 1975;36: Nakanishi K, Inoue M, Sugawara E, Sano S. Ischemic and reperfusion injury of cyanotic myocardium in chronic hypoxic rat model: changes in cyanotic myocardial antioxidant system. J Thorac Cardiovasc Surg 1997;114: Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides 1. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem 1972;247: Schluter KD, Weber M, Schraven E, Piper HM. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Am J Physiol 1994;267:H Agullo L, Garcia-Dorado D, Inserte J, et al. l-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cgmp-dependent mechanism. Am J Physiol 1999;276: H Ito N, Bartunek J, Spitzer KW, Lorell BH. Effects of the nitric oxide donor sodium nitroprusside on intracellular ph and contraction in hypertrophied myocytes. Circulation 1997;95: Tajima M, Bartunek J, Weinberg EO, Ito N, Lorell BH. Atrial natriuretic peptide has different effects on contractility and intracellular ph in normal and hypertrophied myocytes from pressure-overload hearts. Circulation 1998;98: Spitzer KW, Bridge JH. Relationship between intracellular ph and tension development in resting ventricular muscle and myocytes. Am J Physiol 1992;262:C Tohse N, Kanno M. Human atrial natriuretic peptide decreases cardiac Ca current through activation of cgmpdependent protein kinase [Abstract]. Jpn J Pharmacol 1993; 61(Suppl 1): Furukawa K, Tawada Y, Shigekawa M. Regulation of the plasma membrane Ca 2 pump by cyclic nucleotides in cultured vascular smooth muscle cells. J Biol Chem 1988;263: Lindpaintner K, Wilhelm MJ, Jin M, et al. Tissue reninangiotensin systems: focus on the heart. J Hypertension 1987;5(Suppl 2):S Linz W, Scholkens BA, Albus U, Petry P, Breipohl G, Knolle J. Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II. J Hypertension 1988;6(Suppl 4):S Morales C, Rodriguez M, Scapin O, Gelpi RJ. Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart. Mol Cell Biochem 1998;186: Walters HL III, Digerness SB, Naftel DC, et al. The response to ischemia in blood perfused versus crystalloid perfused isolated rat heart preparations. J Mol Cell Cardiol 1992;24:
Original Article. Introduction
Original Article The Effects of Na Movement on Surgical Myocardial Protection: The Role of the Na + -H + Exchange System and Na-Channel in the Development of Ischemia and Reperfusion Injury Ke-Xiang Liu,
More information2. Langendorff Heart
2. Langendorff Heart 2.1. Principle Langendorff heart is one type of isolated perfused heart which is widely used for biochemical, physiological, morphological and pharmacological researches. It provides
More informationMyocardial injury that has developed through a
I. PATHOPHYSIOLOGY OF ISCHEMIC REPERFUSION INJURY Cellular Mechanisms of Ischemia-Reperfusion Injury H. Michael Piper, MD, PhD, Karsten Meuter, MD, and Claudia Schäfer, PhD Physiologisches Institut, Justus-Liebig-Universität,
More informationCalcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium
Calcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium E. Jack Baker IV, MD, Gordon N. Olinger, MD, and John E. Baker, PhD Department of Cardiothoracic Surgery, Medical
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationEffect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia
Original Article Effect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia Yunqing Mei, Hua Liu, Cun Long, Bangchang Cheng, Shangzhi Gao and Dayi Hu, Department of Thoracic
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationIt has been shown that the inhibition of Na /H exchange
The Contribution of Na /H Exchange to Ischemia-Reperfusion Injury After Hypothermic Cardioplegic Arrest Takashi Yamauchi, MD, Hajime Ichikawa, MD, Yoshiki Sawa, MD, Norihide Fukushima, MD, Koji Kagisaki,
More informationComparison of the Protective Properties of Four
Comparison of the Protective Properties of Four Clinical Crystalloid Cardioplegic Solutions in the Rat Heart Lary A. Robinson, M.D., Mark V. Braimbridge, F.R.C.S., and David J. Hearse, D.Sc. ABSTRACT Although
More informationEarly reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage
Evolving Technology/Basic Science Rudd and Dobson Early reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage Donna M. Rudd,
More information2. MATERIALS AND METHODS
2. MATERIALS AND METHODS 2.1 Materials [ 3 H]-Digoxin (37Ci/mmol) was purchased from Perkin-Elmer Life Sciences Inc. (Boston, USA) and [U- 14 C]-Sucrose (660mCi/mmol) was purchased from Amersham Bioscience
More informationSupplemental Figure I
Supplemental Figure I Kl ( mmol/l)-induced Force orta M (mn) 1 (mn) 1 Supplemental Figure I. Kl-induced contractions. and, Kl ( mmol/l)-induced contractions of the aorta () and those of mesenteric arteries
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationRelaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate
Pathophysiology 4 (1998) 275 280 Relaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate B.J. Adegunloye, O.A. Sofola
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationComparison of Flow Differences amoiig Venous Cannulas
Comparison of Flow Differences amoiig Venous Cannulas Edward V. Bennett, Jr., MD., John G. Fewel, M.S., Jose Ybarra, B.S., Frederick L. Grover, M.D., and J. Kent Trinkle, M.D. ABSTRACT The efficiency of
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationEFFECTS OF SIGMA RECEPTOR LIGAND BD737 IN RAT ISOLATED HEARTS
SCRIPTA MEDICA (BRNO) 80 (6): 255 262, December 2007 EFFECTS OF SIGMA RECEPTOR LIGAND BD737 IN RAT ISOLATED HEARTS Nováková M. Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech
More informationSUPPLEMENTAL MATERIAL. Supplementary Methods
SUPPLEMENTAL MATERIAL Supplementary Methods Culture of cardiomyocytes, fibroblasts and cardiac microvascular endothelial cells The isolation and culturing of neonatal rat ventricular cardiomyocytes was
More informationSpecial circulations, Coronary, Pulmonary. Faisal I. Mohammed, MD,PhD
Special circulations, Coronary, Pulmonary Faisal I. Mohammed, MD,PhD 1 Objectives Describe the control of blood flow to different circulations (Skeletal muscles, pulmonary and coronary) Point out special
More informationControl of blood tissue blood flow. Faisal I. Mohammed, MD,PhD
Control of blood tissue blood flow Faisal I. Mohammed, MD,PhD 1 Objectives List factors that affect tissue blood flow. Describe the vasodilator and oxygen demand theories. Point out the mechanisms of autoregulation.
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationMyocardial Protection Principles. David J Chambers
David J Chambers Cardiac Surgical Research/Cardiothoracic Surgery The Rayne Institute (King s College London) Guy s & St Thomas NHS Foundation Trust St Thomas Hospital London UK ScanSect, Aarhus, Denmark.
More informationCardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationMcHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload
McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload Cardiac output (CO) represents the volume of blood that is delivered
More informationNitric oxide (NO) is a vasodilatory molecule synthetized
Effects of L-Arginine Administration Before Cardioplegic Arrest on Ischemia-Reperfusion Injury Yusheng Yan, MD, Siamak Davani, MD, Sidney Chocron, MD, Bernadette Kantelip, MD, Patrice Muret, MD, and Jean-Pierre
More informationThe Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest
The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest and Reperfusion on Myocardial Preservation John H. Rousou, M.D., Richard M. Engelman, M.D., William A. Dobbs, Ph.D., and Mooideen
More informationFeasibility of Leadless Cardiac Pacing Using Injectable. Magnetic Microparticles
Supplementary Information for Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic Microparticles Menahem Y. Rotenberg, Hovav Gabay, Yoram Etzion and Smadar Cohen. Correspondence to: scohen@bgu.ac.il,
More informationWeeks 1-3:Cardiovascular
Weeks 1-3:Cardiovascular Cardiac Output The total volume of blood ejected from the ventricles in one minute is known as the cardiac output. Heart Rate (HR) X Stroke Volume (SV) = Cardiac Output Normal
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More informationRole of Ion Fluxes in Hydrogen Peroxide Pulmonary Vasoconstriction
Physiol. Res. 44: 31-3 7, 1995 Role of Ion Fluxes in Hydrogen Peroxide Pulmonary Vasoconstriction J. W ILHELM, J. H E R G E T 1 Department of Medical Chemistry and Biochemistry and department of Physiology,
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationEquivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning
Original Cardiovascular 229 Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning Xujin Xiang 1 Haixia Lin 2 Jin Liu 1 Zeyan Duan 1 1 Department of Anesthesiology, West China Hospital,
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationCardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart
Cardiovascular Physiology Heart Physiology Introduction The cardiovascular system consists of the heart and two vascular systems, the systemic and pulmonary circulations. The heart pumps blood through
More informationCardiac Output 1 Fox Chapter 14 part 1
Vert Phys PCB3743 Cardiac Output 1 Fox Chapter 14 part 1 T. Houpt, Ph.D. Regulation of Heart & Blood Pressure Keep Blood Pressure constant if too low, not enough blood (oxygen, glucose) reaches tissues
More informationCirculation: Chapter 25. Cardiac Output. The Mammalian Heart Fig Right side of the heart
Circulation: Chapter 25 1. Limits of Diffusion A. Small organisms use diffusion B. rapid over small distances 2. Most animals have circulatory systems A. Blood B. Pump (Heart) or propulsive structures
More information4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.
Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the
More informationM myocardial preservation [l], and may act by antagonizing
Myocardial Preservation Related to Magnesium Content of Hyperkalemic Cardioplegic Solutions at 8 C Tommy R. Reynolds, MD, Gillian A. Geffin, MB, BS, James S. Titus, Dennis D. O Keefe, MD, and Willard M.
More informationThe Cardiovascular System (Heart)
The Cardiovascular System The Cardiovascular System (Heart) A closed system of the heart and blood vessels The heart pumps blood Blood vessels allow blood to circulate to all parts of the body The function
More informationBUSINESS. Articles? Grades Midterm Review session
BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization
More informationImproving myocardial preservation after the arrest
Opioid Preconditioning: Myocardial Function and Energy Metabolism Daniel C. Sigg, MD, James A. Coles, Jr, MS, William J. Gallagher, BS, Peter R. Oeltgen, PhD, and Paul A. Iaizzo, PhD Departments of Anesthesiology
More information578 Index. Eplerenone, 7, 29, 119, 120, 126, 275, 276,
Index A AC. See Adenylate cyclase (AC) ACEI. See Angiotensin converting enzyme inhibitors (ACEI) Adenosine, 179, 180, 182 184, 191, 196 198 Adenosine A1 receptor, 179 183, 186, 190 198 Adenylate cyclase
More informationExperimental Study on Myocardial Protection by Adjunct Use of Carperitide (hanp) in Cardiac Surgery
Original Article Experimental Study on Myocardial Protection by Adjunct Use of Carperitide (hanp) in Cardiac Surgery Shinji Wakui, MD Background: In recent years, various beneficial roles of human atrial
More informationHemolysis is a well known complication caused by
Free Hemoglobin Impairs Cardiac Function in Neonatal Rabbit Hearts Shintaro Nemoto, MD, Mitsuru Aoki, MD, Chang Dehua, MD, and Yasuharu Imai, MD Department of Pediatric Cardiovascular Surgery, The Heart
More informationThe Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to:
The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to: 1. Describe the functions of the heart 2. Describe the location of the heart,
More informationThe Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions
Short Communication Japanese Journal of Physiology, 36, 403-409, 1986 The Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions Shun-ichi MIYAMAE
More informationPearson's Comprehensive Medical Assisting Administrative and Clinical Competencies
Pearson's Comprehensive Medical Assisting Administrative and Clinical Competencies THIRD EDITION CHAPTER 27 The Cardiovascular System Lesson 1: Overview of the Cardiovascular System Lesson Objectives Upon
More informationCopyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy
Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationNitric oxide: a trigger for classic preconditioning?
Am J Physiol Heart Circ Physiol 279: H2752 H2765, 2000. Nitric oxide: a trigger for classic preconditioning? AMANDA LOCHNER, 1,2 ERNA MARAIS, 1 SONIA GENADE, 1 AND JOHAN A. MOOLMAN 1 1 Medical Physiology
More informationBasal Ornithine Decarboxylase Activity Modifies Apoptotic and Hypertrophic Marker Expression in Post-Ischemic Hearts
Open Heart Failure Journal,,, - Open Access Basal Ornithine Decarboxylase Activity Modifies Apoptotic and Hypertrophic Marker Expression in Post-Ischemic Hearts Christian Mörlein, Rolf Schreckenberg and
More information5.1. Isolation and Culture of Adult Ventricular Cardiomyocytes. Introduction
557 Isolation and Culture of Adult Ventricular Cardiomyocytes Klaus-Dieter Schlüter and Hans Michael Piper Introduction The current understanding of the physiological and pathophysiological behaviour of
More information(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased
Review Test 1. A 53-year-old woman is found, by arteriography, to have 5% narrowing of her left renal artery. What is the expected change in blood flow through the stenotic artery? Decrease to 1 2 Decrease
More informationAngiotensin-converting enzyme inhibitors potentiate subthreshold preconditioning through NO and mitok ATP. channel
Acta Physiologica Sinica, August 25, 2005, 57 (4): 453-460 http://www.actaps.com.cn 453 ATP 1 1 1 2 2 2,* 1 313000 2 310006 Langendorff ( ) ( ) (angiotensin-converting enzyme inhibitors, ACEI) (nitric
More informationCh.15 Cardiovascular System Pgs {15-12} {15-13}
Ch.15 Cardiovascular System Pgs {15-12} {15-13} E. Skeleton of the Heart 1. The skeleton of the heart is composed of rings of dense connective tissue and other masses of connective tissue in the interventricular
More informationEffect of an increase in coronary perfusion on transmural. ventricular repolarization
Effect of an increase in coronary perfusion on transmural ventricular repolarization Yan-Zhou Zhang 1, MD, PhD, Ben He 1, MD, Le-Xin Wang 2, MD, PhD. From: 1 Department of Cardiology, Renji Hospital, Medical
More informationFAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION
Br. J. clin. Pharmac. (1982), 14, 187S-19lS BENEFICIAL EFFECTS OF CAPTOPRIL IN LEFT VENTRICULAR FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION J.P. BOUNHOURE, J.G. KAYANAKIS, J.M. FAUVEL & J. PUEL Departments
More informationCVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery
CVICU EXAM 1111 North 3rd Street Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery 1. Nursing standards for a patient on an IABP device include: a. Know results of
More informationBUFFERING OF HYDROGEN LOAD
BUFFERING OF HYDROGEN LOAD 1. Extracellular space minutes 2. Intracellular space minutes to hours 3. Respiratory compensation 6 to 12 hours 4. Renal compensation hours, up to 2-3 days RENAL HYDROGEN SECRETION
More informationEffect of an Increase in Coronary Perfusion on Transmural Ventricular Repolarization
Physiol. Res. 56: 285-290, 2007 Effect of an Increase in Coronary Perfusion on Transmural Ventricular Repolarization Y.-Z. ZHANG 1, B. HE 1, L.-X. WANG 2 1 Department of Cardiology, Renji Hospital, Medical
More informationCardiovascular system
BIO 301 Human Physiology Cardiovascular system The Cardiovascular System: consists of the heart plus all the blood vessels transports blood to all parts of the body in two 'circulations': pulmonary (lungs)
More informationLeft atrial function. Aliakbar Arvandi MD
In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial
More informationElectrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated ischemia
Acta Pharmacol Sin 2007 Aug; 28 (8): 1155 1160 Short communication Electrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated
More informationPHYSIOLOGY MeQ'S (Morgan) All the following statements related to blood volume are correct except for: 5 A. Blood volume is about 5 litres. B.
PHYSIOLOGY MeQ'S (Morgan) Chapter 5 All the following statements related to capillary Starling's forces are correct except for: 1 A. Hydrostatic pressure at arterial end is greater than at venous end.
More informationActa Physiologica Sinica
, 1999 4, 51 (2), 187 192 187 Acta Physiologica Sinica 3 1998204222 1998206203 3 (No139500052) 3 3, 221002 3 3 3 3 3 (, 200031) ( Ito), 28 d (H28, 6 h/ d), Ito (16118 4161 6132 1135 pa/ pf, P < 0105),
More informationInt J Clin Exp Pathol 2015;8(4): /ISSN: /IJCEP Ling Liu, Hui Yue, Bing Guo, Xin He, Jing Wang, Jin-Cheng Li
Int J Clin Exp Pathol 2015;8(4):3843-3849 www.ijcep.com /ISSN:1936-2625/IJCEP0005843 Original Article Nitric oxide donor, NOC7, reveals dose dependently and cgmp pathway independently biphasic effects
More informationHeart Failure. Acute. Plasma [NE] (pg/ml) 24 Hours. Chronic
Heart Failure Heart failure is the inability of the heart to deliver sufficient blood to the tissues to ensure adequate oxygen supply. Clinically it is characterized by signs of volume overload or symptoms
More informationBlood Functions. Blood and the Cardiovascular System. Blood. Plasma. Erythrocytes (RBCs) Erythrocytes (RBCs) 4/7/2017
Blood Functions Blood and the Cardiovascular System Distribution Delivery of oxygen and nutrients to all body cells; Transport of wastes to lungs and excretory organs; Transport of hormones Regulation
More informationMyocardial Infarction: Left Ventricular Failure
CARDIOVASCULAR PHYSIOLOGY 93 Case 17 Myocardial Infarction: Left Ventricular Failure Marvin Zimmerman is a 52-year-old construction manager who is significantly overweight. Despite his physician's repeated
More informationArun Govindapillai. Submitted in partial fulfilment of the requirements for the degree of Master of Science
Protecting The Aged Heart During Cardiac Surgery: Use Of Del Nido Cardioplegia Provides Superior Functional Recovery In Isolated Hearts by Arun Govindapillai Submitted in partial fulfilment of the requirements
More informationLab 16. The Cardiovascular System Heart and Blood Vessels. Laboratory Objectives
Lab 16 The Cardiovascular System Heart and Blood Vessels Laboratory Objectives Describe the anatomical structures of the heart to include the pericardium, chambers, valves, and major vessels. Describe
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationSymBioSys Exercise 2 Cardiac Function Revised and reformatted by C. S. Tritt, Ph.D. Last updated March 20, 2006
SymBioSys Exercise 2 Cardiac Function Revised and reformatted by C. S. Tritt, Ph.D. Last updated March 20, 2006 The goal of this exercise to explore the behavior of the heart as a mechanical pump. For
More informationThe Cardiovascular System
The Cardiovascular System The Cardiovascular System A closed system of the heart and blood vessels The heart pumps blood Blood vessels allow blood to circulate to all parts of the body The function of
More informationHawthorn Extract - Viable Treatment for Cardiovascular Disease or Unscrupulous Herbal Supplement?
Grand Valley State University ScholarWorks@GVSU Student Summer Scholars Undergraduate Research and Creative Practice 2010 Hawthorn Extract - Viable Treatment for Cardiovascular Disease or Unscrupulous
More informationGUIDELINE PHYSIOLOGY OF BIRTH ASPHYXIA
GUIDELINE PHYSIOLOGY OF BIRTH ASPHYXIA The newborn is not an adult, nor a child. In people of all ages, death can occur from a failure of breathing and / or circulation. The interventions required to aid
More informationPrevious experimental evidence indicates that some cardiovascular
Report Downloaded from http://circres.ahajournals.org/ by guest on July 1, 2018 Autocrine Stimulation of Cardiac Na -Ca 2 Exchanger Currents by Endogenous Endothelin Released by Angiotensin II Ernesto
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationAnatomy and Physiology, Spring 2015 Exam II: Form A April 9, Name Student Number
Anatomy and Physiology, Spring 2015 Exam II: Form A April 9, 2015 Name Student Number For Questions 1 2 refer to the following table. 1 Ventricular pressure is greater than aortic 6 AV valve is open 2
More informationReperfusion injury in STEMI. Therapeutic opportunities David Garcia-Dorado. Barcelona. Spain
Reperfusion injury in STEMI. Therapeutic opportunities David Garcia-Dorado. Barcelona. Spain 1. The problem 2. Reperfusion injury after acute coronary occlusion 3. Ischemic conditioning 4. Pharmacological
More informationTopics to be Covered. Cardiac Measurements. Distribution of Blood Volume. Distribution of Pulmonary Ventilation & Blood Flow
Topics to be Covered MODULE F HEMODYNAMIC MONITORING Cardiac Output Determinants of Stroke Volume Hemodynamic Measurements Pulmonary Artery Catheterization Control of Blood Pressure Heart Failure Cardiac
More information*Generating blood pressure *Routing blood: separates. *Ensuring one-way blood. *Regulating blood supply *Changes in contraction
*Generating blood pressure *Routing blood: separates pulmonary and systemic circulations *Ensuring one-way blood flow: valves *Regulating blood supply *Changes in contraction rate and force match blood
More informationE and the heart: Possible role as antioxidant. Acta Vitaminol. Enzymol. 5: 11-22, ) Jolly, S. R., Kane, W. J., Bailie, M. B. et al.
1) Ferrari, R., Visoli, O., Guarnieri, C. et al.: Vitamin E and the heart: Possible role as antioxidant. Acta Vitaminol. Enzymol. 5: 11-22, 1983. 2) Jolly, S. R., Kane, W. J., Bailie, M. B. et al.: Canine
More informationCardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology
Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart
More informationAge-related changes in cardiovascular system. Dr. Rehab Gwada
Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results
More informationPharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)
Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,
More informationChapter 9, Part 2. Cardiocirculatory Adjustments to Exercise
Chapter 9, Part 2 Cardiocirculatory Adjustments to Exercise Electrical Activity of the Heart Contraction of the heart depends on electrical stimulation of the myocardium Impulse is initiated in the right
More informationRadnoti Langendorff Constant Pressure Non-Recirculating Pump Driven Isolated Heart System For Mouse EZ
Radnoti Langendorff Constant Pressure Non-Recirculating Pump Driven Isolated Heart System For Mouse Radnoti 2006 Description Qty Part # Base only, for 4-bar stand 1 159950-B4 Stabilizer Bar only, for 4-Bar
More informationPotassium Efflux from Myocardial Cells Induced by Defibrillator Shock
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1986 Potassium Efflux from Myocardial Cells Induced by Defibrillator
More information11/10/2014. Muscular pump Two atria Two ventricles. In mediastinum of thoracic cavity 2/3 of heart's mass lies left of midline of sternum
It beats over 100,000 times a day to pump over 1,800 gallons of blood per day through over 60,000 miles of blood vessels. During the average lifetime, the heart pumps nearly 3 billion times, delivering
More informationRV dysfunction and failure PATHOPHYSIOLOGY. Adam Torbicki MD, Dept Chest Medicine Institute of Tuberculosis and Lung Diseases Warszawa, Poland
RV dysfunction and failure PATHOPHYSIOLOGY Adam Torbicki MD, Dept Chest Medicine Institute of Tuberculosis and Lung Diseases Warszawa, Poland Normal Right Ventricle (RV) Thinner wall Weaker myocytes Differences
More informationHigh Ca Content of Pacemaker Tissues in the Frog Heart
Short Communication Japanese Journal of Physiology, 34, 1117-1121,1984 High Ca Content of Pacemaker Tissues in the Frog Heart Yasuichiro FUKUDA Department of Physiology II, School of Medicine, Chiba University,
More informationProtection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia
Protection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia Matthias Karck, MD, Gerhard Ziemer, MD, Max Zoeller, MD, Steffen Schulte, MD, Klaus-D. Juergens, MD, Herwig Weisser, MD, and
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationMechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations. Eric M. Graham, MD
Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations Eric M. Graham, MD Background Heart & lungs work to meet oxygen demands Imbalance between supply
More information